Michel Detheux

CIK 1816196 · Chief Executive Officer · last filed 2025-08-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$0

Companies

2

Total Filings

26

Lifetime Open-Market Net

-$10.04M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
iTeos Therapeutics, Inc. (ITOS) Delisted	Chief Executive Officer	0	$10.15	$0	-$10.04M	25	2025-08-29
VOR	Director	—	$14.36	—	$0	1	2025-07-18

Recent Filings · Page 3 of 3

26 filings

Form 4 transactions across all companies, newest first.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-09-03	iTeos Therapeutics, Inc. (ITOS) Delisted	Sell (S)	−20,252	-$580.5K	EDGAR
2021-08-31	iTeos Therapeutics, Inc. (ITOS) Delisted	Sell (S)	−14,663	-$412.5K	EDGAR
2021-08-25	iTeos Therapeutics, Inc. (ITOS) Delisted	Sell (S)	−8,585	-$240.9K	EDGAR
2021-06-16	iTeos Therapeutics, Inc. (ITOS) Delisted	Sell (S)	−29,000	-$826.5K	EDGAR
2021-03-03	iTeos Therapeutics, Inc. (ITOS) Delisted	Grant (A)	—	$0	EDGAR
2020-07-24	iTeos Therapeutics, Inc. (ITOS) Delisted	Grant (A)	—	$0	EDGAR

Showing 21–26 of 26

Prev Page 3 of 3

Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.